Damian Bialonczyk

Company: Roche

Job title: Global Medical Lead - Metabolism

Seminars:

Harnessing Biased Signaling to Enhance Incretin Pharmacodynamics 8:30 am - 9:00 am

Developing GLP-1 receptor agonists that preferentially activate pathways leading to enhanced glucose-dependent insulin secretion while minimizing pathways associated with adverse effects Approaches for accurately assessing incretin pharmacodynamics in humans Utilizing biased signaling to achieve personalized medicineRead more

day: Day One